Invus Financial Advisors LLC

Invus Financial Advisors LLC latest Q4_2020 13F filings reported $239,241,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 15.09%. This fund has 6 securities concentrations of 100% weights.

Invus Financial Advisors LLC largest holding is NovoCure Limited Ordinary Shares with weight of 25.38% and $60,717,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR6$239,241,00015.09%
2020-11-162020-09-30Q3_202013F-HR6$207,867,000-24.87%
2020-08-142020-06-30Q2_202013F-HR9$276,678,00035.83%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
NOVOCURE LTDNVCRINCR$60,71755.46%25.38%$173.04-100.00%350,884
OYSTER PT PHARMA INCOYSTDECR$52,105-10.85%21.78%$18.820.00%2,768,586
ARCUS BIOSCIENCES INCRCUSINCR$47,82051.46%19.99%$25.96-100.00%1,842,077
YEXT INCYEXTDECR$38,755-22.18%16.20%$15.72-124.86%2,465,308
ORIC PHARMACEUTICALS INCORICINCR$34,10635.35%14.26%$33.85-100.00%1,007,575
UNITY BIOTECHNOLOGY INCUBXINCR$5,73851.44%2.40%$5.24-100.00%1,094,998